AirNet Announces Receipt of Deficiency Letter from Nasdaq
BEIJING, Jan. 05, 2024 (GLOBE NEWSWIRE) — AirNet Technology Inc., formerly known as AirMedia Group Inc. (the “Company”) (Nasdaq: ANTE), […]
OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029
MIAMI, Jan. 04, 2024 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) (the “Company”) today announced the pricing of its […]
Dyne Therapeutics Announces Pricing of $300 Million Public Offering of Common Stock
WALTHAM, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) — Dyne Therapeutics, Inc. (Nasdaq:DYN), a clinical-stage muscle disease company focused on advancing innovative […]
Voyager Therapeutics Announces Pricing of Public Offering
LEXINGTON, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic […]
Standard BioTools Stockholders Approve Merger with SomaLogic
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) — Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose […]
FormFactor Inc. To Present At The 26th Annual Needham Growth Conference
LIVERMORE, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) — FormFactor, Inc. (Nasdaq: FORM) is pleased to announce its participation in the 26th […]
Texas Capital Bancshares, Inc. Announces Date for Full Year and Q4 2023 Operating Results
DALLAS, Jan. 04, 2024 (GLOBE NEWSWIRE) — Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital Bank, […]
Ekso Bionics Reports Certain Preliminary Fourth Quarter and Full Year 2023 Financial Results
SAN RAFAEL, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) — Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader […]
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues
TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to […]
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023
ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing […]
